These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30338558)

  • 41. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Vedak P; Kroshinsky D
    J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Topical treatment of alopecia areata].
    Krajáková O; Kachnic M; Harbulák J; Hermanová E; Petrusová T; Rimegová K; Demková A
    Cesk Dermatol; 1975 Aug; 50(4):241-5. PubMed ID: 1157113
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral tofacitinib for the treatment of alopecia areata in pediatric patients.
    Kibbie J; Kines K; Norris D; Dunnick CA
    Pediatr Dermatol; 2022 Jan; 39(1):31-34. PubMed ID: 34779041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Translational impact of omics studies in alopecia areata: recent advances and future perspectives.
    Basmanav FB; Betz RC
    Expert Rev Clin Immunol; 2022 Aug; 18(8):845-857. PubMed ID: 35770930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two case studies of persistent white hair regrowth after alopecia areata turning pigmented following treatment.
    Tian Z; Liu Q; Wang Y; Yang D
    J Cosmet Dermatol; 2024 Jul; 23(7):2490-2495. PubMed ID: 38500297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alopecia areata update.
    Alkhalifah A
    Dermatol Clin; 2013 Jan; 31(1):93-108. PubMed ID: 23159179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study.
    Ezzedine K; Visseaux L; Cadiot G; Brixi H; Bernard P; Reguiai Z
    J Dermatol; 2019 Apr; 46(4):322-327. PubMed ID: 30816581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hair regrowth following TNF-α blockade in coexisting psoriasis vulgaris and alopecia areata.
    Ono S; Miyachi Y; Arakawa A
    Eur J Dermatol; 2013; 23(4):537. PubMed ID: 24047580
    [No Abstract]   [Full Text] [Related]  

  • 49. New and Emerging Therapies for Alopecia Areata.
    Pourang A; Mesinkovska NA
    Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PUVA treatment for alopecia areata--does it work? A retrospective review of 102 cases.
    Healy E; Rogers S
    Br J Dermatol; 1993 Jul; 129(1):42-4. PubMed ID: 8369209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of methotrexate in severe childhood alopecia areata.
    Royer M; Bodemer C; Vabres P; Pajot C; Barbarot S; Paul C; Mazereeuw J
    Br J Dermatol; 2011 Aug; 165(2):407-10. PubMed ID: 21517797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata.
    Özdemir M; Balevi A
    Pediatr Dermatol; 2017 Mar; 34(2):128-132. PubMed ID: 28044367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids.
    Lee D; Hong SK; Park SW; Hur DY; Shon JH; Shin JG; Hwang SW; Sung HS
    Exp Dermatol; 2010 Feb; 19(2):145-7. PubMed ID: 19758343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral Methotrexate Monotherapy for Severe Alopecia Areata: A Single Center Retrospective Case Series.
    Kinoshita-Ise M; Sachdeva M; Martinez-Cabriales SA; Shear NH; Lansang P
    J Cutan Med Surg; 2021 Sep; 25(5):490-497. PubMed ID: 33715460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis.
    Kanameishi S; Dainichi T; Endo Y; Otsuka A; Tanioka M; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e137-e138. PubMed ID: 27532876
    [No Abstract]   [Full Text] [Related]  

  • 56. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata.
    Bhat S; Handa S; De D
    Indian J Dermatol Venereol Leprol; 2021; 87(1):42-48. PubMed ID: 33580923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of pediatric alopecia areata: A systematic review.
    Barton VR; Toussi A; Awasthi S; Kiuru M
    J Am Acad Dermatol; 2022 Jun; 86(6):1318-1334. PubMed ID: 33940103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
    El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.